Human Immunodeficiency Virus (HIV) Infections (AIDS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Human Immunodeficiency Virus Pipeline market research report provides a comprehensive overview on the therapeutics under development for Human Immunodeficiency Virus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Human Immunodeficiency Virus and features dormant and discontinued projects.
Key Targets in the Human Immunodeficiency Virus Pipeline Drugs Market
In the HIV pipeline drugs market the key targets are Reverse Transcriptase, Surface Protein gp12, Gag, HIV 1 Integrase, Glycoprotein 41, T Cell Surface Glycoprotein CD4, HIV 1 Retropepsin, P27, Pol Polyprotein, Capsid Protein, and Glycoprotein 140.
Human Immunodeficiency Virus Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Human Immunodeficiency Virus Pipeline Drugs Market
Reverse Transcriptase Inhibitor has the highest number of pipeline products followed by Surface Protein gp12 Inhibitor, HIV 1 Integrase Inhibitor, Glycoprotein 41 Inhibitor, T Cell Surface Glycoprotein CD4 Inhibitor, HIV 1 Retropepsin Inhibitor, Capsid Protein Inhibitor, HIV Integrase Inhibitor, C-C Chemokine Receptor Type 5 Antagonist, and Gag Inhibitor.
Human Immunodeficiency Virus Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Human Immunodeficiency Virus Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the HIV pipeline drugs market are Oral, Intramuscular, Intravenous, Subcutaneous, Parenteral, Topical, Vaginal, Intradermal, Rectal, and Nasal. Oral has the maximum number of pipeline products.
Human Immunodeficiency Virus Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Human Immunodeficiency Virus Pipeline Drugs Market
The key molecule types in the HIV pipeline drugs market are Small Molecule, Monoclonal Antibody, Subunit Vaccine, Recombinant Vector Vaccine, Gene-Modified Cell Therapy, Synthetic Peptide, DNA Vaccine, Vaccine, Cell Therapy, and mRNA Vaccine.
Human Immunodeficiency Virus Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Human Immunodeficiency Virus Pipeline Drugs Market
The major companies in the HIV pipeline drugs market are Gilead Sciences Inc, ViiV Healthcare UK Ltd, Merck & Co Inc, Viriom Inc, Aphios Corp, Enochian Biosciences Inc, Statera Biopharma Inc, Johnson & Johnson, OyaGen Inc, and TaiMed Biologics Inc.
Human Immunodeficiency Virus Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Human Immunodeficiency Virus Pipeline Drugs Market Overview
Key Targets | Reverse Transcriptase, Surface Protein gp12, Gag, HIV 1 Integrase, Glycoprotein 41, T Cell Surface Glycoprotein CD4, HIV 1 Retropepsin, P27, Pol Polyprotein, Capsid Protein, and Glycoprotein 140 |
Key Mechanisms of action | Reverse Transcriptase Inhibitor, Surface Protein gp12 Inhibitor, HIV 1 Integrase Inhibitor, Glycoprotein 41 Inhibitor, T Cell Surface Glycoprotein CD4 Inhibitor, HIV 1 Retropepsin Inhibitor, Capsid Protein Inhibitor, HIV Integrase Inhibitor, C-C Chemokine Receptor Type 5 Antagonist, and Gag Inhibitor |
Key Routes of Administration | Oral, Intramuscular, Intravenous, Subcutaneous, Parenteral, Topical, Vaginal, Intradermal, Rectal, and Nasal |
Key molecule types | Small Molecule, Monoclonal Antibody, Subunit Vaccine, Recombinant Vector Vaccine, Gene-Modified Cell Therapy, Synthetic Peptide, DNA Vaccine, Vaccine, Cell Therapy, and mRNA Vaccine |
Major companies | Gilead Sciences Inc, ViiV Healthcare UK Ltd, Merck & Co Inc, Viriom Inc, Aphios Corp, Enochian Biosciences Inc, Statera Biopharma Inc, Johnson & Johnson, OyaGen Inc, and TaiMed Biologics Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Human Immunodeficiency Virus
- The pipeline guide reviews pipeline therapeutics for Human Immunodeficiency Virus by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Human Immunodeficiency Virus therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Human Immunodeficiency Virus therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Human Immunodeficiency Virus
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective countercstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Human Immunodeficiency Virus
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Human Immunodeficiency Virus pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
AbbVie Inc
Abivax SA
Acceleromics SL
Actinobac Biomed Inc
Adare Pharma Solutions
Advanced Gene and Cell Technologies
Aelix Therapeutics SL
AiCuris Anti-infective Cures AG
AIM ImmunoTech Inc
AlbaJuna Therapeutics
Alphamab Oncology
AlphaVax Inc
American Gene Technologies International Inc
Amgen Inc
Antion Biosciences SA
Aphios Corp
Apimeds Inc
Ascletis Pharma Inc
AUM LifeTech Inc
Auro Vaccines LLC
Autonomous Therapeutics Inc
Avixgen Inc
B Cell Design SAS
Bionor Holding AS
BioNTech SE
Biosantech SA
Biotron Ltd
Bolder Biotechnology Inc
Brandenburg Antiinfektiva GmbH
Brii Biosciences Ltd
Bristol-Myers Squibb Co
BryoLogyx Inc
Bukwang Pharmaceutical Co Ltd
Celdara Medical LLC
Celldex Therapeutics Inc
Centivax Inc
Chiesi Farmaceutici SpA
Cidara Therapeutics Inc
Clover Biopharmaceuticals Ltd
Cocrystal Pharma Inc
Codiak BioSciences Inc
Collaborations Pharmaceuticals Inc
Consegna Pharma Inc
ConserV Bioscience Ltd
CSL Ltd
Curevac NV
Cytodyn Inc
CytRx Corp
Dewpoint Therapeutics Inc
DFH Pharma Inc
Diaccurate
E-Vaccines Inc
Emmune Inc
Enochian Biosciences Inc
Enzo Biochem Inc
Enzolytics Inc
EpitoGenesis Inc
EpiVax Inc
eTheRNA Immunotherapies NV
Evotec SE
Exavir Therapeutics Inc
Excision BioTherapeutics Inc
ExQor Technologies Inc
Fox Chase Chemical Diversity Center Inc
Frontier Biotechnologies Inc
FUJIFILM Toyama Chemical Co Ltd
GB Sciences Inc
GeneCure Biotechnologies LLC
Genetic Immunity Inc
GeoVax Labs Inc
Gilead Sciences Inc
Globeimmune Inc
Greffex Inc
Gritstone Bio Inc
GT Biopharma Inc
Guangzhou Bio-gene Technology Co Ltd
HDT Bio Corp
Helocyte Biosciences Inc
Hepion Pharmaceuticals Inc
Hetero Drugs Ltd
Hoverink Biotechnologies Inc
ID Pharma Co Ltd
IGXBio Inc
Immune Modulation Inc
Immune Response BioPharma Inc
ImmunityBio Inc
Immuno Cure BioTech Ltd
Immunocore Limited
Immunologik GmbH
Indaptus Therapeutics Inc
Innovare R & D SA De CV
Inovio Pharmaceuticals Inc
Intarcia Therapeutics Inc
Intrucept Biomedicine LLC (Inactive)
InvVax Inc
ISR Immune System Regulation Holding AB
Ithax Pharmaceuticals Inc
Jericho Sciences LLC
Jiangsu Aidea Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Johnson & Johnson
Kainos Medicine Inc
Kanglin Biotech Hangzhou Co Ltd
Karyopharm Therapeutics Inc
Lauren Sciences LLC
Legend Biotech Corp
Longevity Biotech Inc
Luckwel Pharmaceuticals Inc
Lyndra Therapeutics Inc.
MacroGenics Inc
Mapp Biopharmaceutical Inc
MarPam Pharma LLC
Merck & Co Inc
METiS Pharmaceuticals
Miltenyi Biotec BV & Co KG
Minka Therapeutics SA
Moderna Inc
Molecular Express Inc
Moleculin Biotech Inc
Mologen AG
Mutabilis SA
Mycenax Biotech Inc
Mymetics Corp
NanoViricides Inc
Navigen Inc
NeED Pharma srl
Neuraxpharm France SAS
New World Laboratories Inc
NovalGen Ltd
Novartis AG
Novodux
Omeros Corp
Oncotelic Inc
Oncovir Inc
OncXerna Therapeutics Inc
Oneness Biotech Co Ltd
Orion Biotechnology Canada Ltd
Osel Inc
OyaGen Inc
Palisades Therapeutics
Pepscan Therapeutics BV
Pharmasyntez
Pharmsynthez
Phoenix Biotechnology Inc
PlantForm Corp
Prosetta Biosciences Inc
Protheragen Inc
PROVIREX Genome Editing Therapies GmbH
Qura Therapeutics LLC
Recombio SL
ReiThera Srl
Repair Biotechnologies Inc
Replikins Ltd
Resverlogix Corp
RetroVirox Inc
Rodos BioTarget GmbH
Samjin Pharm Co Ltd
Sangamo Therapeutics Inc
Satellos Bioscience Inc
Savoy Pharmaceuticals Inc
Seagen Inc
Secura Bio Inc
Serum Institute of India Pvt Ltd
Shanghai De Novo Pharmatech Co Ltd
Shanghai Pharmaceutical Group Co Ltd
Shanghai Record Pharmaceuticals Co Ltd
Shanxi Kangbao Biological Product Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Shionogi & Co Ltd
SignalRx Pharmaceuticals Inc
Sirga Advanced Biopharma Inc
ST Pharm Co Ltd
Staidson BioPharma Inc
Starpharma Holdings Ltd
Statera Biopharma Inc
Sumagen Co Ltd
Sunomix Therapeutics
Susavion Biosciences Inc
Taiga Biotechnologies Inc
TaiMed Biologics Inc
Takara Bio Inc
TechnoVax Inc
Tetranov International Inc
Tevogen Bio Inc
TheraJect Inc
Theratechnologies Inc
Theravectys SA
Transgene Biotek Ltd
Transposon Therapeutics Inc
TVAX Biomedical Inc
United Biomedical Inc
Uvax Bio LLC
Vault Pharma Inc
VG Life Sciences Inc
Vichem Chemie Research Ltd
viIMMUNE
ViiV Healthcare UK Ltd
Vir Biotechnology Inc
Viramatix Sdn Bhd
Viravaxx AG
Viriom Inc
ViroStatics SRL
Winsantor Inc
Wuhan Bio-Raid Biotechnology Co Ltd
Xi'An Yufan Biotechnology Co Ltd
Xyphos Biosciences Inc
Yaso Therapeutics Inc
Yisheng Biopharma Co Ltd
Zata Pharmaceuticals Inc
Zion Medical
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Human Immunodeficiency Virus pipeline drugs market?
In the Human Immunodeficiency Virus pipeline drugs market the key targets are Reverse Transcriptase, Surface Protein gp12, Gag, HIV 1 Integrase, Glycoprotein 41, T Cell Surface Glycoprotein CD4, HIV 1 Retropepsin, P27, Pol Polyprotein, Capsid Protein, and Glycoprotein 140.
-
What are the key mechanisms of action in the Human Immunodeficiency Virus pipeline drugs market?
In the Human Immunodeficiency Virus pipeline drugs market the key mechanisms of action are Reverse Transcriptase Inhibitor, Surface Protein gp12 Inhibitor, HIV 1 Integrase Inhibitor, Glycoprotein 41 Inhibitor, T Cell Surface Glycoprotein CD4 Inhibitor, HIV 1 Retropepsin Inhibitor, Capsid Protein Inhibitor, HIV Integrase Inhibitor, C-C Chemokine Receptor Type 5 Antagonist, and Gag Inhibitor.
-
What are the key routes of administration in the Human Immunodeficiency Virus pipeline drugs market?
The key routes of administration in the Human Immunodeficiency Virus pipeline drugs market are Oral, Intramuscular, Intravenous, Subcutaneous, Parenteral, Topical, Vaginal, Intradermal, Rectal, and Nasal.
-
What are the key molecule types in the Human Immunodeficiency Virus pipeline drugs market?
The key molecule types in the Human Immunodeficiency Virus pipeline drugs market are Small Molecule, Monoclonal Antibody, Subunit Vaccine, Recombinant Vector Vaccine, Gene-Modified Cell Therapy, Synthetic Peptide, DNA Vaccine, Vaccine, Cell Therapy, and mRNA Vaccine.
-
What are the major companies in the Human Immunodeficiency Virus pipeline drugs market?
In the Human Immunodeficiency Virus pipeline drugs market the major companies are Gilead Sciences Inc, ViiV Healthcare UK Ltd, Merck & Co Inc, Viriom Inc, Aphios Corp, Enochian Biosciences Inc, Statera Biopharma Inc, Johnson & Johnson, OyaGen Inc, and TaiMed Biologics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.